MIGS: Expanding realm of glaucoma

Success requires picking the right patient, setting proper expectations, and learning technique. » Read how MIGS is affecting glaucoma

Editorial: What dying wishes or regrets might ophthalmologists have?

In his latest column, Peter J. McDonnell, MD, Ophthalmology Times' chief medical editor, ponders what regrets physicians may have when they reach the end of their lives. » Click to read Dr. McDonnell's editorial

How OCT became a 'game changer'

Joel Schuman, MD, discusses his role in its development, future of patient care for glaucoma. » Read Dr. Schuman's discussion

First-in-class glaucoma therapy shows promise in 28-day phase II study

Therapy significantly lowered IOP in eyes with ocular hypertension or open-angled glaucoma. » Click to read about the new glaucoma therapy

In the pipeline: Novel MIGS stents in various stages of trials

New devices to lower IOP and facilitate aqueous outflow via minimally invasive glaucoma surgery are being developed, and early results from clinical trials are favorable for some. » Read about the new devices

Every clinic has 'characters,' how to manage them is key

No matter the practice, there will always be bullies, divas, and ‘that guy’ on staff. » Read how to manage your staff of characters

• Questions remain if anti-VEGF therapy influences atrophy in neovascular AMD

• Ophthalmology remembers friend, LASIK pioneer Dr. George Waring III

• Expert hints: 7 ways to avoid HIPAA violations via social media

• Why intensive diagnostic evaluation, management of peripheral ulcerative keratitis is a must

Downloads

You are subscribed to the Ophthalmology Times Issue Alert.